The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial.
Gemma M AustinKaty KnightJoanne BellAnthony CarterEarnest HeartinDavid WatsonLetizia ForoniStephen E ChristmasFotios PolydorosRichard E ClarkPublished in: British journal of haematology (2018)